Companies: 10,795·Total market cap: $144.5T
Exactus, Inc.

Exactus, Inc.

EXDIOTCHealthcare
$0.07
$-0.01(-10.96%)
Market Cap$0
P/E Ratio
52W High$0.073
52W Low$0.0505

Exactus, Inc. (EXDI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

exdi · pe ratio · data through Dec 31, 2020

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Exactus, Inc. (EXDI) measures how much investors pay for each dollar of the company's trailing earnings. EXDI's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of -$0.22.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2020-12-31

Forward P/E
N/A
EPS (TTM)
-$0.22
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Exactus, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2011 – 2020 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Exactus, Inc.
Exactus, Inc.You
EXDI
N/A-$0.22
Acreage Holdings, Inc.
Acreage Holdings, Inc.
ACRDF
$5MN/A-$0.61
The BC Bud Corporation
The BC Bud Corporation
BCBCF
$6MN/A-$0.03
China Infrastructure Construction Corp.
China Infrastructure Construction Corp.
CHNC
$5MN/A-$0.00
CLS Holdings USA, Inc.
CLS Holdings USA, Inc.
CLSH
$6MN/A-$0.05
The Flowr Corporation
The Flowr Corporation
FLWPF
$0MN/A-$0.23
Immune Therapeutics, Inc.
Immune Therapeutics, Inc.
IMUN
$8MN/A-$0.16

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2020-12-31Latest
FY2020
$-0.22
2019-12-31
FY2019
$-0.29
2018-12-31
FY2018
$-0.91
2017-12-31
FY2017
$-0.91
2016-12-31
FY2016
$-0.67
2015-12-31
FY2015
$-5.59
2014-12-31
FY2014
$-4.60
2013-12-31
FY2013
$-0.33
2012-12-31
FY2012
$-1.00
2011-12-31
FY2011
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Exactus, Inc. (EXDI) measures how much investors pay for each dollar of the company's trailing earnings. EXDI's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of -$0.22.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.07 ÷ -$0.22 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EXDI pe ratio · 6 questions

EXDI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.07 and TTM EPS of -$0.22. Data sourced from Financial Modeling Prep via EXDI's SEC 10-K and 10-Q filings.

EXDI PE ratioWhat is EXDI PE ratioCurrent PE ratio of EXDIEXDI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Exactus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09